Changchun BCHT Biotechnology Co. (688276.SS)

CNY 23.21

(0.09%)

Total Liabilities Summary of Changchun BCHT Biotechnology Co.

  • Changchun BCHT Biotechnology Co.'s latest annual total liabilities in 2023 was 1.01 Billion CNY , up 40.33% from previous year.
  • Changchun BCHT Biotechnology Co.'s latest quarterly total liabilities in 2024 Q3 was 1.11 Billion CNY , up 10.57% from previous quarter.
  • Changchun BCHT Biotechnology Co. reported annual total liabilities of 724.01 Million CNY in 2022, down -4.36% from previous year.
  • Changchun BCHT Biotechnology Co. reported annual total liabilities of 757.05 Million CNY in 2021, up 10.11% from previous year.
  • Changchun BCHT Biotechnology Co. reported quarterly total liabilities of 1.01 Billion CNY for 2024 Q1, down -0.46% from previous quarter.
  • Changchun BCHT Biotechnology Co. reported quarterly total liabilities of 1 Billion CNY for 2024 Q2, down -0.39% from previous quarter.

Annual Total Liabilities Chart of Changchun BCHT Biotechnology Co. (2023 - 2017)

Historical Annual Total Liabilities of Changchun BCHT Biotechnology Co. (2023 - 2017)

Year Total Liabilities Total Liabilities Growth
2023 1.01 Billion CNY 40.33%
2022 724.01 Million CNY -4.36%
2021 757.05 Million CNY 10.11%
2020 687.56 Million CNY 20.56%
2019 570.28 Million CNY -6.62%
2018 610.74 Million CNY 12.59%
2017 542.44 Million CNY 0.0%

Peer Total Liabilities Comparison of Changchun BCHT Biotechnology Co.

Name Total Liabilities Total Liabilities Difference
Jiang Zhong Pharmaceutical Co.,Ltd 1.6 Billion CNY 36.677%
Zhejiang Shengda Bio-Pharm Co., Ltd. 449.19 Million CNY -126.187%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 440.92 Million CNY -130.43%
Nanjing Well Pharmaceutical Group Co.,Ltd. 686.22 Million CNY -48.06%
Ningbo Menovo Pharmaceutical Co., Ltd. 2.23 Billion CNY 54.598%
Lionco Pharmaceutical Group Co.,Ltd. 693.51 Million CNY -46.502%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.64 Billion CNY 72.158%
ChengDu ShengNuo Biotec Co.,Ltd. 431.06 Million CNY -135.697%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.6 Billion CNY 36.658%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 3.49 Billion CNY 70.906%
Yabao Pharmaceutical Group Co., Ltd 860.33 Million CNY -18.096%
Shanghai Shyndec Pharmaceutical Co., Ltd. 4.89 Billion CNY 79.228%
Hubei Jumpcan Pharmaceutical Co., Ltd. 4.7 Billion CNY 78.394%
Zhongzhu Healthcare Holding Co.,Ltd 422.34 Million CNY -140.568%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 1.03 Billion CNY 1.53%
Tibet Weixinkang Medicine Co., Ltd. 436.54 Million CNY -132.74%
Shandong Buchang Pharmaceuticals Co., Ltd. 9.2 Billion CNY 88.961%
Shenzhen Chipscreen Biosciences Co., Ltd. 1.54 Billion CNY 34.028%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 299.24 Million CNY -239.523%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 696.15 Million CNY -45.948%
KPC Pharmaceuticals, Inc. 3.9 Billion CNY 73.983%
Shanghai Jiaoda Onlly Co.,Ltd 475.91 Million CNY -113.487%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.49 Billion CNY 31.914%
Guobang Pharma Ltd. 2.92 Billion CNY 65.258%
Shanghai Yizhong Pharmaceutical Co., Ltd. 107.05 Million CNY -849.079%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 2.24 Billion CNY 54.727%
Harbin Pharmaceutical Group Co., Ltd. 8.37 Billion CNY 87.862%
Beijing Tongrentang Co., Ltd 9.67 Billion CNY 89.498%
Henan Lingrui Pharmaceutical Co., Ltd. 1.97 Billion CNY 48.51%
Tasly Pharmaceutical Group Co., Ltd 3.86 Billion CNY 73.714%
Kangmei Pharmaceutical Co., Ltd. 7.19 Billion CNY 85.888%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 4.42 Billion CNY 77.04%
Humanwell Healthcare (Group) Co.,Ltd. 15.38 Billion CNY 93.397%
China Animal Husbandry Industry Co., Ltd. 2.38 Billion CNY 57.371%
Ginwa Enterprise (Group) Inc. 470.12 Million CNY -116.117%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.65 Billion CNY 38.428%
Mayinglong Pharmaceutical Group Co., LTD. 959.61 Million CNY -5.878%
Henan Taloph Pharmaceutical Stock Co.,Ltd 1.95 Billion CNY 47.902%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 2.2 Billion CNY 54.022%
Dali Pharmaceuticalco.,Ltd 92.7 Million CNY -995.926%
Shandong Lukang Pharmaceutical Co.,Ltd. 4.95 Billion CNY 79.475%
HPGC Renmintongtai Pharmaceutical Corporation 4.55 Billion CNY 77.69%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 805.75 Million CNY -26.095%
Zhejiang Medicine Co., Ltd. 2.79 Billion CNY 63.625%
Zhejiang Huahai Pharmaceutical Co., Ltd. 10.34 Billion CNY 90.182%
Jianmin Pharmaceutical Group Co.,Ltd. 1.89 Billion CNY 46.323%
CanSino Biologics Inc. 3.86 Billion CNY 73.716%
Sichuan Huiyu Pharmaceutical Co., Ltd. 886.91 Million CNY -14.556%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 1.6 Billion CNY 36.842%
Hunan Warrant Pharmaceutical Co.,Ltd 358.76 Million CNY -183.199%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.47 Billion CNY 31.009%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.38 Billion CNY 70.021%
Joincare Pharmaceutical Group Industry Co.,Ltd. 13.34 Billion CNY 92.388%
North China Pharmaceutical Company Ltd. 14.68 Billion CNY 93.081%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 3.52 Billion CNY 71.186%
Zhejiang Hisun Pharmaceutical Co., Ltd. 9.26 Billion CNY 89.032%
Chongqing Taiji Industry(Group) Co.,Ltd 10.52 Billion CNY 90.347%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 40.9 Billion CNY 97.516%
China National Medicines Corporation Ltd. 14.87 Billion CNY 93.169%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 515.97 Million CNY -96.914%
Cisen Pharmaceutical Co., Ltd. 1.57 Billion CNY 35.342%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 56.77 Billion CNY 98.21%
Zhejiang Starry Pharmaceutical Co.,Ltd. 3.66 Billion CNY 72.303%
Tibet Rhodiola Pharmaceutical Holding Co. 1.18 Billion CNY 14.468%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 1.33 Billion CNY 24.087%